TABLE 3.

The risk estimate for the myocardial revascularization based on the UA quartiles.

	Q1	Q2	Q3	Q4	P for trend
Total
Myocardial revascularization, n (%)	2,487 (70.9%)	2,223 (61.8%)	2,061 (58.2%)	2,047 (57.2%)
Model 1	Ref.	0.68 (0.61,0.76)	0.61 (0.55,0.68)	0.58 (0.52,0.64)	<0.001
Model 2	Ref.	0.76 (0.68,0.86)	0.63 (0.51,0.70)	0.57 (0.51,0.64)
Male
Myocardial revascularization, n (%)	1,691 (72.0%)	1,556 (61.2%)	1,531 (59.3%)	1,557 (58.2%)
Model 1	Ref.	0.64 (0.57,0.74)	0.62 (0.55,0.70)	0.59 (0.52,0.69)	<0.001
Model 2	Ref.	0.61 (0.53,0.69)	0.60 (0.47,0.68)	0.58 (0.51,0.70)
Female
Myocardial revascularization, n (%)	796 (68.6%)	667 (63.0%)	530 (55.2%)	490 (54.0%)
Model 1	Ref.	0.77 (0.64,0.93)	0.56 (0.46,0.68)	0.52 (0.43,0.64)	<0.001
Model 2	Ref.	0.68 (0.59,0.88)	0.50 (0.44,0.67)	0.47 (0.32,0.65)

Models 1: adjusted for age, gender.

Models 2: adjusted for age, gender, BMI, SBP, SUA, creatinine, HDL-C, TC, RBC, WBC, PLT, statin use, current smoker, current drinker, diabetes, and hypertension.

BMI, body mass index; HDL-C, high density lipoprotein cholesterol; PLT, platelets; RBC, red blood cell count; SBP, systolic blood pressure; SUA, serum uric acid; WBC, white blood cell count; TC, total cholesterol.